Fludeoxyglucose F18

Active Ingredient(s): Fludeoxyglucose F-18
FDA Approved: * January 13, 2014
Pharm Company: * UNIV TX MD ANDERSON
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Fludeoxyglucose F18 Overview

Fludeoxyglucose (18F) (INN), or fludeoxyglucose F 18 (USAN and USP), also commonly called fluorodeoxyglucose and abbreviated [18F]FDG, 18F-FDG or FDG, is a radiopharmaceutical used in the medical imaging modality positron emission tomography (PET). Chemically, it is 2-deoxy-2-(18F)fluoro-D-glucose, a glucose analog, with the positron-emitting radionuclide fluorine-18 substituted for the normal hydroxyl group at the C-2 position in the glucose molecule. The uptake of 18F-FDG by tissues is a ma...

Read more Fludeoxyglucose F18 Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fludeoxyglucose_(18F)

Recent Fludeoxyglucose F18 Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fludeoxyglucose F-18
  • Injection: 10-100mci/ml, 20-150mci/ml, 20-200mci/ml, 20-240mci/ml, 20-300mci/ml, 20-400mci/ml, 20-500mci/ml, 20mci/ml - 300mci/ml, 4-40mci/ml, 4-500mci/ml, 4-90mci/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fludeoxyglucose F18: (14 results)

Sorted by National Drug Code
  • 13267-123 Fludeoxyglucose F18 300 mci/Ml Intravenous Injection by The Feinstein Institute for Medical Research
  • 13267-234 Fludeoxyglucose 400 mci/Ml Intravenous Injection by The Feinstein Institute for Medical Research
  • 24275-0185 Fludeoxyglucose F18 300 mci/Ml Intravenous Injection by Ucsf Radiopharmaceutical Facility
  • 24562-001 Fludeoxyglucose 300 mci/Ml Intravenous Injection, Solution by Biomedical Research Foundation of Northwest Louisiana
  • 24562-003 Fludeoxyglucose F18 300 mci/Ml Intravenous Injection, Solution by Biomedical Research Foundation of Northwest Louisiana
  • 44338-001 Fludeoxyglucose F18 500 mci/Ml Intravenous Injection, Solution by Wisconsin Medical Cyclotron LLC
  • 47584-001 Fludeoxyglucose 500 mci/Ml Intravenous Injection by Cyclotron Partners Lp Dba Cyclotope
  • 51760-001 Fludeoxyglucose F18 300 mci/Ml Intravenous Injection by Essential Isotopes LLC
  • 60215-411 Fludeoxyglucose 300 mci/Ml Intravenous Injection by The University of Texas Md Anderson Cancer Center
  • 69587-001 Fludeoxyglucose 300 mci/Ml Intravenous Injection by Mips Cyclotron & Radiochemistry Facility
  • 69815-754 Fludeoxyglucose F18 300 mci/Ml Intravenous Injection by Memorial Sloan Kettering Cancer Center
  • 69864-001 Fludeoxyglucose F18 .3 Ci/Ml Intravenous Injection, Solution by The Methodist Hospital Research Institute
  • 76326-001 Fludeoxyglucose 300 mci/Ml Intravenous Injection by The Regents of The University of Michigan
  • 76451-118 Fludeoxyglucose 300 mci/Ml Intravenous Injection by 3d Imaging Drug Design and Development LLC

Other drugs which contain Fludeoxyglucose F-18 or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA